Abstract
The form II of Rotigotine (RTG), a dopamine agonist used to treat Parkinson's disease and Wills-Ekbom disease, is a stable crystal that is suitable for industrial production. In our study, we measured the solubility of RTG in ten solvents, including alcohols and esters, using UV spectrophotometry at temperatures ranging from 278.15 to 313.15 K and atmospheric pressure. Our results showed an increasing trend in solubility with temperature and an increase in carbon chain length of the solvents, except for 2-propanol and isopropyl acetate. By fitting six thermodynamic models to the solubility data, we found strong correlation. Simulation calculations indicated that HH and CH bonds are dominant among RTG molecules, and the solubility of RTG has a positive trend with the increase in viscosity and carbon chain length of the solvents.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
